Join 60 Degrees Pharmaceuticals' Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization
RedChip Companies will host an investor webinar on Tuesday, November 10, 2026, at 4:15 p.m. ET with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP). The exclusive event will feature Geoff Dow, Chairman and CEO, who will provide an overview of 60 Degrees Pharmaceuticals' strategy to develop and commercialize therapies for vector-borne diseases. The presentation will focus on the Company's FDA-approved antimalarial ARAKODA® (tafenoquine), its...
Read more








